1. Controlling Nutritional Status (CONUT) Score is Associated with Overall Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Cohort Study
- Author
-
Kazunori Noguchi, Shusuke Okamura, Yoshinori Yokokura, Taizo Yamaguchi, Hideki Iwamoto, Miki Ono, Hideya Suga, Ken Miyazaki, Takuji Torimura, Takumi Kawaguchi, Tomotake Shirono, Shigeo Shimose, Masahito Nakano, Takashi Niizeki, Hironori Koga, and Masatoshi Tanaka
- Subjects
Male ,Prognostic variable ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Nutritional Status ,lcsh:TX341-641 ,Antineoplastic Agents ,lenvatinib ,Gastroenterology ,Article ,Cohort Studies ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Internal medicine ,controlling nutritional status ,Medicine ,Humans ,Nutritional Physiological Phenomena ,Aged ,Nutrition and Dietetics ,business.industry ,Phenylurea Compounds ,Hazard ratio ,Liver Neoplasms ,Retrospective cohort study ,hepatoma ,medicine.disease ,Confidence interval ,BCLC Stage ,Survival Rate ,chemistry ,Research Design ,030220 oncology & carcinogenesis ,Hepatocellular carcinoma ,Quinolines ,030211 gastroenterology & hepatology ,Female ,prognosis ,business ,Lenvatinib ,lcsh:Nutrition. Foods and food supply ,Food Science ,Cohort study - Abstract
We aimed to investigate the impact of the controlling nutritional status (CONUT) score, an immuno-nutritional biomarker, on the prognosis of patients with hepatocellular carcinoma (HCC) treated with lenvatinib (LEN). This retrospective study enrolled 164 patients with HCC and treated with LEN (median age 73 years, Barcelona Clinic Liver Cancer (BCLC) stage B/C 93/71). Factors associated with overall survival (OS) were evaluated using multivariate and decision tree analyses. OS was calculated using the Kaplan&ndash, Meier method and analyzed using the log&ndash, rank test. Independent factors for OS were albumin&ndash, bilirubin grade 1, BCLC stage B, and CONUT score <, 5 (hazard ratio (HR) 2.9, 95% confidence interval (CI) 1.58&ndash, 5.31, p <, 0.001). The CONUT score was the most important variable for OS, with OS rates of 70.0% and 29.0% in the low and high CONUT groups, respectively. Additionally, the median survival time was longer in the low CONUT group than in the high CONUT group (median survival time not reached vs. 11.3 months, p <, 0.001). The CONUT score was the most important prognostic variable, rather than albumin&ndash, bilirubin grade and BCLC stage, in patients with HCC treated with LEN. Accordingly, immuno-nutritional status may be an important factor in the management of patients with HCC treated with LEN.
- Published
- 2020
- Full Text
- View/download PDF